Capecitabine Induced Onycholysis
Department of Medical Oncology, American Oncology Institute, Hyderabad, India
International Journal of Clinical Case Reports, 2015, Vol. 5, No. 40 doi: 10.5376/ijccr.2015.05.0040
Received: 29 Jun., 2015 Accepted: 30 Jul., 2015 Published: 07 Oct., 2015
© 2015 BioPublisher Publishing Platform
This is an open access article published under the terms of the Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Preferred citation for this article:
Krishnamani K.V., 2015, Capecitabine Induced Onycholysis, International Journal of Clinical Case Reports, 5(40): 1-3 (doi: 10.5376/ijccr.2015.05.0040)
A 61 year old gentleman with metastatic gastric carcinoma received palliative chemotherapy with Epirubicin, Oxaliplatin and Capecitabine. While on capecitabine maintenance he developed serous discharge from the toenails and ultimately painless loss of the nails. A diagnosis of capecitabine induced onycholysis was made and after symptomatic treatment and discontinuation of the drug his symptoms improved. Capecitabine induced onycholysis has not been reported very often in literature and the identification and diagnosis of this entity is important in patients who are treated with this commonly prescribed drug.
Capecitabine; Nail changes; Onycholysis
International Journal of Clinical Case Reports
• Volume 5